Objective: This article analyzed the clinical efficacy and tolerability of rivaroxaban and
enoxaparin in patients undergoing total knee arthroplasty (TKA) surgery. Methods: Five …

Introduction Thromboprophylaxis following total hip and knee arthroplasty is variable across
institutions, but commonly consists of enoxaparin, and more recently rivaroxaban. We aimed …

Venous thromboembolism (VTE) is the most widespread severe complication after total hip
arthroplasty (THA) and total knee arthroplasty (TKA). We conducted this meta-analysis to …

Background We investigated the efficacy of rivaroxaban, an orally active direct factor Xa
inhibitor, in preventing venous thrombosis after total knee arthroplasty. Methods In this …

Objective A meta-analysis of randomized controlled trials (RCTs) was performed to compare
the efficacy and safety of direct factor Xa inhibitors (rivaroxaban and apixaban) with …

Introduction: Rivaroxaban is a novel, oral, direct Factor Xa inhibitor in advanced clinical
development for the prevention and treatment of thromboembolic disorders, including the …

Purpose To investigate the incidence of venous thromboembolism (VTE) after total knee
arthroplasty (TKA) with chemoprophylaxis using acetylsalicylic acid (AA) or rivaroxaban in …

Background Prophylaxis for venous thromboembolism is recommended for at least 10 days
after total knee arthroplasty; oral regimens could enable shorter hospital stays. We aimed to …

Background: The purpose of this meta-analysis is to compare the efficacy and safety of
aspirin and rivaroxaban in the prevention of venous thromboembolism (VTE) following either …

Background There is a high risk of developing venous thromboembolism (VTE) following
total knee arthroplasty (TKA). Conventional thromboprophylactic agents have limitations …